Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShires Inc. Regulatory News (SHRS)

Share Price Information for Shires Inc. (SHRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 235.00
Bid: 229.00
Ask: 234.00
Change: 7.00 (3.07%)
Spread: 5.00 (2.183%)
Open: 235.00
High: 235.00
Low: 235.00
Prev. Close: 228.00
SHRS Live PriceLast checked at -
Shires Income is an Investment Trust

To invest principally in the ordinary shares of UK quoted companies, and in preference shares, convertibles and other fixed income securities with above average yields.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Propose combination with abrdn Smaller Co Inc Trst

26 Jul 2023 07:00

RNS Number : 1808H
Shires Income PLC
26 July 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, ANY MEMBER STATE OF THE EEA, OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

 

This announcement is not an offer to sell, or a solicitation of an offer to acquire, securities in the United States or in any other jurisdiction in which the same would be unlawful. Neither this announcement, nor any part of it, shall form the basis of, or be relied upon in connection with, or act as an inducement to enter into, any contract or commitment whatsoever.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended. On the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For immediate release

 

 

26 July 2023

 

Shires Income plc ("Shires" or the "Company")

 

Proposed combination with abrdn Smaller Companies Income Trust plc ("ASCI")

 

Introduction

 

The Board of the Company is pleased to announce that it has agreed terms with the board of ASCI for a combination of the assets of ASCI and Shires (the "Proposals"). Both investment trusts, which are managed by abrdn Fund Managers Limited ("abrdn"), have UK equity income as a key part of their investment objectives, including exposure to UK smaller companies.

 

The Proposals

 

The Proposals will be implemented through a scheme of reconstruction and voluntary winding up of ASCI under section 110 of the Insolvency Act 1986 and the associated transfer of assets to the Company (the "Scheme").

Subject to the approval of shareholders of both companies, the Scheme will give ASCI shareholders the choice between receiving new ordinary shares of 50p each in the capital of Shires ("New Ordinary Shares") (the "Rollover" and "Rollover Option"); and/or cash (the "Cash Option"). If the Scheme is approved, ASCI shareholders will Rollover into Shires unless they specifically elect for the Cash Option for all or part of their holding. For the avoidance of doubt, the Cash Option will be unlimited, with all valid elections to receive cash accepted.

ASCI expects to pay out the vast majority of its accumulated revenue reserves via a pre-liquidation dividend to all ASCI shareholders, and intends to repay its floating rate credit facility prior to the implementation of the Scheme.

Shires' entitlements as a shareholder in ASCI under the Scheme will be satisfied on ASCI's liquidation by the transfer of the Rollover assets to the Company (which will include Shires' pro rata share of ASCI's assets) without any issue of New Ordinary Shares to Shires under the Scheme.

The enlarged Shires will continue to be managed by abrdn in accordance with its existing investment objective: namely to provide a high level of income together with the potential for growth of both income and capital from a diversified portfolio, substantially invested in UK equities but also in preference shares, convertibles and other fixed income securities. Shires will continue to have exposure to UK small caps, though holding assets directly rather than indirectly via its shareholding in ASCI. The Company will be managed on the same management terms, and with the aim of providing the same dividend levels as Shires shareholders have received in the year to 31 March 2023, namely 14.20p per share, which represents a yield of 6.1 per cent. based on Shires' share price as at 24 July 2023. Shires shares have traded at an average discount to net asset value ("NAV") of 1.5 per cent. over the twelve months to 24 July 2023 and Shires has periodically issued new shares to meet demand.

Benefits of the Proposals

Shareholders in the enlarged Shires are expected to benefit from:

· an increase in scale, allowing the enlarged Shires to spread fixed costs over a larger asset base and to benefit from the tiered management fee structure, while also potentially improving secondary liquidity and aiding marketability; and

· a differentiated UK equity income strategy with an attractive dividend, with some exposure to smaller companies and fixed income securities.

 

The Proposals are also expected to deliver benefits 1 to ASCI's shareholders, whether they wish to Rollover into Shires or wish to elect for the Cash Option.

· Payout of revenue reserves via pre-liquidation dividend:

It is expected that the vast majority of ASCI's accumulated revenue reserves will be paid out before the Scheme becomes effective

All of ASCI's shareholders will be entitled to receive the pre-liquidation dividend, whether they elect for the Rollover Option or the Cash Option

For those shareholders electing to Rollover into Shires:

· Increased dividend:

An expected increase of 44.7 per cent. per annum in dividend income based on the most recent four dividends for each company (i.e. a full year's dividend)

· Reduced costs:

Expected decrease of 31.9 per cent. in ongoing charges ratio ("OCR") based on the pro forma OCR of the enlarged Shires as compared with the last published OCR of ASCI

A large part of this reduction is due to Shires' management fee, being 0.45 per cent. of NAV (including any borrowings up to a maximum of £30m, and excluding commonly managed funds) per annum up to and including £100m and 0.40 per cent. of NAV (as above) per annum in excess of £100m

· Improved average rating:

Over the twelve months to 24 July 2023, Shires' shares traded at an average 1.5 per cent. discount to NAV, compared to ASCI's shares which traded at an average 13.2 per cent. discount to NAV

As at 24 July 2023, the latest practicable date prior to publication of this announcement, the discounts to NAV at which ASCI's shares and Shires' shares traded were, respectively, 17.1 per cent. and 7.9 per cent

· Shires' historic investment performance 2:

Shires NAV total return over 1, 3 and 5 years (measured to 24 July 2023) has been 4.5 per cent., 25.8 per cent. and 16.1 per cent. respectively

Shires share price total return over 1, 3 and 5 years (measured to 24 July 2023) has been -3.4 per cent., 20.5 per cent. and 12.2 per cent. respectively

· Significant cost contribution by abrdn and notice period waiver

abrdn will offer a cost contribution to the Scheme by waiving the management fee payable by Shires to abrdn that would have been due in respect of the ASCI assets rolling over to Shires for a period of six months following implementation of the Scheme (to the benefit of all shareholders of the enlarged Shires). The reduction will be calculated by reference to the percentage that those assets represent of the enlarged Shires at the point of implementation of the Scheme.

abrdn has also undertaken to waive, in full, the period of notice to which it is contractually entitled under the management contract that it has with ASCI and has agreed that no compensation will be payable by ASCI to abrdn in respect of such wavier

· Continued UK smaller companies exposure:

Circa 40 per cent. of the ASCI portfolio is expected to be transferred in specie to Shires, ensuring continued UK small cap exposure for all Shires shareholders, with the expectation being that UK small cap exposure will represent up to 20 per cent. of Shires' portfolio on an ongoing basis

For those electing for the Cash Option:

· Unlimited cash exit:

All ASCI shareholders will have the ability to elect up to 100 per cent. of their holding in ASCI for cash

Further details on the Proposals

The Proposals will be subject to inter alia the approval of shareholders of ASCI and Shires, as well as regulatory and tax approvals.

 

The formula asset value ("FAV") of ASCI (the "ASCI FAV") and the FAV of Shires (the "Shires FAV") will be calculated, for the purposes of the Scheme, in accordance with the respective company's normal accounting policies. FAVs will be calculated based on the NAV (cum income with debt at fair value) of each company, on a calculation date to be agreed by both parties, with any necessary adjustments made, and will be reviewed by an independent accountant.

Shires will be protected from asset and income dilution under the Proposals through the issue of New Ordinary Shares at a 0.80 per cent. premium to NAV. As part of the Scheme, Shires, the largest beneficial shareholder in ASCI, holding approximately 13.6 per cent. of ASCI's issued share capital as at 24 July 2023, will vote its full holding in favour of the Scheme.

 

Shareholders of ASCI who elect for the Cash Option for all of part of their shareholding will receive an amount in cash equal to 98.5 per cent of the value of assets attributable to the Cash Option (after realising any non-cash assets so attributed), with the balance being applied for the benefit of the Rollover Option.

Each party will bear its own costs in respect of the Proposals, whether or not the Proposals proceed. 

For the avoidance of doubt, any costs of realignment and/or realisation of the ASCI portfolio prior to the Scheme becoming effective will be borne by ASCI. Any stamp duty, stamp duty reserve tax or other transaction tax, or investment costs incurred by Shires for the acquisition of the ASCI portfolio or the deployment of the cash therein upon receipt shall be borne by the enlarged Shires. The London Stock Exchange admission fees payable in connection with the issue of New Ordinary Shares to ASCI shareholders will also be borne by the enlarged Shires.

 

Shires following implementation of the Scheme

It is intended that the Shires portfolio will continue to be managed on the same basis as it is currently, though Shires' exposure to UK small caps will be through direct investments rather than via its shareholding in ASCI. It is expected that up to 20 per cent. of the enlarged Shires' portfolio will be UK small caps on an ongoing basis.

The Shires portfolio is managed by abrdn, led by Iain Pyle and Charles Luke. Shires also has access to abrdn's Smaller Companies team, including drawing on the expertise of ASCI's portfolio managers Abby Glennie and Amanda Yeaman. Shires' existing management fees of 0.45 per cent. of NAV (including any borrowings up to a maximum of £30m, and excluding commonly managed funds) up to and including £100m and 0.40 per cent. of NAV (as above) in excess of £100m per annum will continue to be charged. A new administration fee of £120,000 plus VAT per annum, effective from the completion of the Scheme, will also be payable by Shires to abrdn. Shires' gearing will remain subject to a maximum equity gearing level of 35 per cent. of net assets at the time of draw down (for information, net gearing was 22.2 per cent. drawn down as at 31 March 2023) and the Shires board has no current intention of increasing the Company's borrowing above the loan facility already in place following implementation of the Proposals.

Timetable

It is anticipated that the documentation in connection with the Scheme will be posted to shareholders in September 2023, with a view to convening general meetings in October/November 2023 in order to complete the transaction by that time.

A further announcement is expected when ASCI and Shires publish their respective Scheme documents.

Robert Talbut, Shires' chairman, commented "The Recommended Proposals are good for both Shires and ASCI shareholders and will create a combined entity that will have greater scale and lower ongoing charges, whilst continuing to pay a higher than average dividend. The Board believes that there is clear investment and structural rationale for the combination, with both sets of shareholders benefiting from greater economies of scale and retaining the expertise of the same management group."

Important Information

This announcement contains information that is inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended. The person responsible for arranging for the release of this announcement on behalf of the Company is Gordon Hay-Smith of abrdn Holdings Limited.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

Past performance is not a guide to future performance. The value of investments, and the income or capital entitlement which may derive from them, if any, may go down as well as up and is not guaranteed. The information contained in this announcement is for background purposes only and does not purport to be full or complete and may not be used in making any investment decision. Nothing in this announcement constitutes investment advice and any recommendations that may be contained herein have not been based upon a consideration of the investment objectives, financial situation or particular needs of any specific recipient. No representation or warranty is given to the achievement or reasonableness of future projections, management targets, estimates, prospects or returns, if any. The information contained in this announcement will not be updated.

 

 

1Unless otherwise stated illustrative financial effects within this section are based on figures as at or to 24 July 2023 and exclude any impact from ASCI's portfolio realisation costs. All figures are illustrative only, using currently available information and estimates. Assumes 25 per cent. of ASCI's issued share capital will elect for the Cash Option. All figures are subject to change. Past performance is not a guide to future performance. The value of investments, and the income or capital entitlement which may derive from them, if any, may go down as well as up and is not guaranteed.

 

2 Source: Refinitiv Datastream

 

 

Enquiries:

Robert Talbut, Chair

0207 463 6000

 

William Simmonds / Rupert Budge, J.P. Morgan Cazenove

0203 493 8000

 

Guy Norfolk/Claire Armstrong, Dentons UK and Middle East LLP

0207 002 8568

 

Legal Entity Identifier: 549300HVCIHNQNZAYA89

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGZNZKVGFZZ
Date   Source Headline
2nd May 202412:59 pmRNSNet Asset Value(s)
30th Apr 202412:55 pmRNSNet Asset Value(s)
30th Apr 202411:20 amRNSGearing disclosure
29th Apr 202412:38 pmRNSNet Asset Value(s)
26th Apr 202412:45 pmRNSNet Asset Value(s)
25th Apr 20241:27 pmRNSNet Asset Value(s)
24th Apr 202412:11 pmRNSNet Asset Value(s)
23rd Apr 202412:47 pmRNSNet Asset Value(s)
22nd Apr 20242:04 pmRNSGearing disclosure
22nd Apr 202412:19 pmRNSNet Asset Value(s)
19th Apr 202412:46 pmRNSNet Asset Value(s)
18th Apr 202412:36 pmRNSNet Asset Value(s)
17th Apr 202412:08 pmRNSNet Asset Value(s)
16th Apr 20241:00 pmRNSNet Asset Value(s)
15th Apr 20245:43 pmRNSPortfolio Disclosures
15th Apr 20243:27 pmRNSGearing Disclosures
15th Apr 202412:46 pmRNSNet Asset Value(s)
12th Apr 202412:56 pmRNSNet Asset Value(s)
12th Apr 202411:24 amRNSCompliance with Market Abuse Regulation
11th Apr 202412:41 pmRNSNet Asset Value(s)
10th Apr 202412:53 pmRNSNet Asset Value(s)
9th Apr 202411:59 amRNSNet Asset Value(s)
8th Apr 20242:46 pmRNSGearing disclosure
8th Apr 20241:00 pmRNSNet Asset Value(s)
5th Apr 202412:33 pmRNSNet Asset Value(s)
4th Apr 202412:47 pmRNSNet Asset Value(s)
3rd Apr 20245:20 pmRNSQuarterly disclosure
3rd Apr 202412:47 pmRNSNet Asset Value(s)
2nd Apr 20243:33 pmRNSGearing disclosure
2nd Apr 202410:10 amRNSTotal Voting Rights
28th Mar 20245:47 pmRNSTransaction in Own Shares
28th Mar 20242:04 pmRNSNet Asset Value(s)
28th Mar 20241:50 pmRNSDirector/PDMR Shareholding
27th Mar 20245:28 pmRNSTransaction in Own Shares
27th Mar 202412:19 pmRNSNet Asset Value(s)
26th Mar 20245:21 pmRNSTransaction in Own Shares
26th Mar 202412:23 pmRNSNet Asset Value(s)
25th Mar 20245:35 pmRNSTransaction in Own Shares
25th Mar 20243:58 pmRNSGearing disclosure
25th Mar 202412:06 pmRNSNet Asset Value(s)
22nd Mar 20245:24 pmRNSTransaction in Own Shares
22nd Mar 202412:16 pmRNSNet Asset Value(s)
21st Mar 20245:17 pmRNSTransaction in Own Shares
21st Mar 20241:17 pmRNSNet Asset Value(s)
20th Mar 202411:45 amRNSNet Asset Value(s)
19th Mar 202412:24 pmRNSNet Asset Value(s)
18th Mar 20242:19 pmRNSGearing Disclosure
18th Mar 202411:46 amRNSNet Asset Value(s)
15th Mar 202412:22 pmRNSNet Asset Value(s)
14th Mar 20243:46 pmRNSPortfolio disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.